These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25612314)

  • 1. Inhibition of RANKL-dependent cellular fusion in pre-osteoclasts by amiloride and a NHE10-specific monoclonal antibody.
    Mine Y; Shuto T; Nikawa H; Kawai T; Ohara M; Kawahara K; Ohta K; Kukita T; Terada Y; Makihira S
    Cell Biol Int; 2015 Jun; 39(6):696-709. PubMed ID: 25612314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of sodium and potassium ion-dependent adenosine triphosphatase-α1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.
    Makihira S; Nikawa H; Kajiya M; Kawai T; Mine Y; Kosaka E; Silva MJ; Tobiume K; Terada Y
    Eur J Pharmacol; 2011 Nov; 670(2-3):409-18. PubMed ID: 21945676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells.
    Abe K; Yoshimura Y; Deyama Y; Kikuiri T; Hasegawa T; Tei K; Shinoda H; Suzuki K; Kitagawa Y
    Int J Mol Med; 2012 Jun; 29(6):1007-15. PubMed ID: 22447156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation.
    Yang M; Birnbaum MJ; MacKay CA; Mason-Savas A; Thompson B; Odgren PR
    J Cell Physiol; 2008 May; 215(2):497-505. PubMed ID: 18064667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profile of osteoclast membrane proteins: identification of Na+/H+ exchanger domain containing 2 and its role in osteoclast fusion.
    Ha BG; Hong JM; Park JY; Ha MH; Kim TH; Cho JY; Ryoo HM; Choi JY; Shin HI; Chun SY; Kim SY; Park EK
    Proteomics; 2008 Jul; 8(13):2625-39. PubMed ID: 18600791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
    Yoshida T; Flegler A; Kozlov A; Stern PH
    J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
    Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
    Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells.
    Suzuki N; Yoshimura Y; Deyama Y; Suzuki K; Kitagawa Y
    Int J Mol Med; 2008 Mar; 21(3):291-6. PubMed ID: 18288375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CD26 signaling inhibits human osteoclast development.
    Nishida H; Suzuki H; Madokoro H; Hayashi M; Morimoto C; Sakamoto M; Yamada T
    J Bone Miner Res; 2014 Nov; 29(11):2439-55. PubMed ID: 24821427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
    Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
    Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of differentiation and function of osteoclasts by dimethyl sulfoxide (DMSO).
    Yang C; Madhu V; Thomas C; Yang X; Du X; Dighe AS; Cui Q
    Cell Tissue Res; 2015 Dec; 362(3):577-85. PubMed ID: 26224539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
    Lee SK; Goldring SR; Lorenzo JA
    Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-κB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-κB-induced RAW264.7 cells.
    Wang X; Zhu Y; Zheng S; Ni C; Zhao L; Liu C; Chen A; Xiao J
    Mol Med Rep; 2015 May; 11(5):3451-6. PubMed ID: 25592168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY
    Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.